Stay updated on Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page’s displayed UI revision label was updated from v3.5.2 to v3.5.3, reflecting a software/version change rather than a change to the underlying clinical trial record.
    Difference
    0.1%
    Check dated 2026-04-24T16:50:07.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 was added. The existing revision entry v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-17T13:45:39.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision history now includes v3.5.0; the v3.4.3 entry was removed.
    Difference
    0.1%
    Check dated 2026-03-19T20:42:42.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.4.3 and no longer lists Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T17:59:42.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    A new site-wide revision entry (Revision: v3.4.2) was added to the history, and an older notice (Revision: v3.4.1) was removed; no study-specific content appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T09:22:20.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    A new site notice about government funding is now shown, and the release note Revision: v3.4.1 was added. The previous Revision: v3.4.0 was removed.
    Difference
    0.7%
    Check dated 2026-02-04T05:32:15.000Z thumbnail image

Stay in the know with updates to Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.